Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

Year: 2019
Year: 2019
Year: 2019
Year: 2019
4th Advanced ECCO: EduCational COurse for Industry: _340.pdf3
Year: 2019
Authors: /moodleneu/blocks/exalib/scripts/presentation2019/25002
51204
4th Advanced ECCO: EduCational COurse for Industry: _342.pdf18
Year: 2019
Authors: /moodleneu/blocks/exalib/scripts/presentation2019/25003
51204
4th Advanced ECCO: EduCational COurse for Industry: _344.pdf18
Year: 2019
Authors: /moodleneu/blocks/exalib/scripts/presentation2019/25004
51204
Session 1: Individualized therapy: The role of prognostic biomarkers
Year: 2019
Authors: Shomron Ben-Horin
ANCA, ASCA, other serum markers,
Session 2: From phase 3 to first-line use
Year: 2019
Authors: Laurent Peyrin-Biroulet
Anti-TNF agents,
Session 3: Challenges in paediatric study design
Year: 2019
Authors: Anne Griffiths
Paediatric,
DOP01: The effect of vedolizumab on CD8 T cell repertoire homogeneity and blood-gut trafficking in patients with inflammatory bowel diseaseECCO’23 Copenhagen
Year: 2023
Authors: Williams, K.(1);Shows, D.(2);Kongala, R.(2);Clarke, A.(3);Lord, J.(2)*;
(1)University of Colorado, Medicine, Denver, United States;(2)Benaroya Research Institute, Translational Research, Seattle, United States;(3)Seattle Genetics, Early Stage Ind to Medicine Research, Seattle, United States;
DOP02: Single cell RNA sequencing of Ulcerative Colitis and Crohn's Disease tissue samples informs the selection of Triggering Receptors Expressed on Myeloid Cells 1 (TREM1) as a target for the treatment of Inflammatory Bowel DiseasesECCO’23 Copenhagen
Year: 2023
Authors: Grant, S.(1)*;Johnson, K.(1);Thomas, T.(2);Honig, G.(1);Bielecki, P.(1);Dendrou, C.(3);Guo, S.(1);Kulicke, R.(1);Li, P.(1);L'Italien, L.(1);Spies, N.(1);Stransky, N.(1);Uhlig, H.(4);Varma, M.(1);Travis, S.(5);Buckley, C.(2);Magram, J.(1);
(1)Celsius Therapeutics, Research and Development, Cambridge MA, United States;(2)Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom;(3)Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom;(4)Translational Gastroenterology Unit and Department of Pediatrics, University of Oxford, Oxford, United Kingdom;(5)Kennedy Institute and Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom;
DOP03: Unfermented β-fructan fibres can induce gut inflammation and tumorigenesis in select Inflammatory Bowel Disease patients mediated by gut microbiotaECCO’23 Copenhagen
Year: 2023
Authors: Voisin, A.(1);Mahmood, R.(2);Jeanson, T.L.(2);Bernstein, C.(2);Armstrong, H.(2)*;
(1)University of Manitoba, Medical Microbiology and Infectious Diseases, Winnipeg, Canada;(2)University of Manitoba, Internal Medicine, Winnipeg, Canada;IBD Clinical and Research Centre
DOP04: Single cell RNA sequencing reveals a potential role for IFNγ in priming circulating monocytes for intestinal inflammatory function in Crohn's Disease.ECCO’23 Copenhagen
Year: 2023
Authors: Hornsby, E.(1)*;Gadhok, R.(1);Yadon, A.N.(2);Lindsay, J.O.(1);Stagg, A.J.(1);
(1)Queen Mary University of London, Blizard Institute, London, United Kingdom;(2)Gilead Sciences- Inc, 199 East Blaine Street, Seattle, United States;